US$ 22.07
glp 1 inhibitor Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 and Anesthesia: Considerations and
Description
Data synthesis and statistical analysis This meta-analysis was performed using Review Manager 5.3 software (RevMan), The Cochrane Collaboration, Copenhagen

doi: 10.1001/jamainternmed.2013.2720

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

The existing medications for treating substance use disorder are underutilized and stigmatized, said Fares Qeadan, associate professor of biostatistics at Loyola University in Chicago

Each patients protocol must be carefully individualized based on their unique health profile, goals, and response to treatment
